Vietnam Pharmaceutical Market Research Report to 2022: Ken Research


Healthcare Market: The healthcare market is explained by cumulative revenues gathered from sales of medical devices, pharmaceuticals, and services provided by private hospitals, and clinical laboratories in Vietnam.

Pharmaceutical Market: The Pharmaceutical Market includes revenue generated from domestic sales of human vaccines and drugs which is obtained from domestic production and imports. Sales of pharmaceuticals to private and public hospitals, pharmacies/drug stores, clinical laboratories (independent labs and physician office labs), polyclinics, community health centers and maternity homes in Vietnam has been considered. Sales of Pharmaceutical drugs have been considered at retail level.

Medical Devices Market: The medical devices market includes total spending by public and private hospitals, clinical laboratories (independent labs and physician office labs), polyclinics and medical research and education institutes on diagnostic imaging equipments, medical consumables, orthopedics and prosthetic devices, dental products, patient aid devices and several other medical equipments. Imported and domestically manufactured medical devices have been considered.

Hospital Market: The hospital and clinic market includes revenue generated by private hospitals established in Vietnam. Revenue from outpatient and inpatient services have been considered. Type of private hospitals considered include single specialty, multi-specialty and general hospitals. Revenue from pharmacy retail though pharmacies located in private hospitals has been included. Revenue generated from walk-in patients for laboratory tests has not been considered. Hospitals with more than 50 beds have been considered.

Clinical Laboratory Market: The clinical laboratory market includes revenue generated from services provided by public and private hospital labs, independent labs and physician office labs for routine, non-laboratory and esoteric tests.

Patented Drug: These are drugs which are covered under patent protection, means that only the pharmaceutical company holding a patent is allowed to manufacture, market the drug and eventually make profit from it.

Generic Drug: These are drugs that are comparable to a brand/reference drug product in dosage form, strength, quality and performance characteristics, and intended use. Once a patent for a patented drug expires, generic versions of the same can be produced.

Prescribed Drugs: These are drugs that can be sold by a pharmacy or drug store only upon prescribed by a registered healthcare practitioner.

OTC Drugs: These are drugs which do not need any prescription and can be purchased directly from any pharmacy or drug store.

Hypothesis Creation: The research team has first framed a hypothesis about the market through analysis of existing industry factors obtained from magazines, journals, broker reports, investor presentations and annual reports of major companies, Ministry of Health Vietnam, Statistical Yearbook of Vietnam.

Hypothesis Testing: The research team conducted computer assisted telephonic interview (CATI) with several industry professionals including decision makers in medical devices, pharmaceuticals, hospitals, and clinical laboratories’ companies. The industry professionals included several importers and distributors of medical devices and pharmaceutical products and doctors, management executives, and other higher level authorities. Structured interviews were conducted through telecom with several industry veterans including major decision makers from Hoan My, Medic Lab, Viet My, Hanh Phuc International Hospital, Nanogen Biopharma, TD Medical Company and other companies. The analyst at Ken Research collated their insights on the market onboard and to seek justification to the hypothesis framed by the team. Additionally several B2B clients from different sectors including government offices, diagnostic centers, and hospitals in the ecosystem have been interviewed to understand their perspectives, needs, requirements and the prices they are willing to pay for procuring medical devices and pharmaceutical drugs.

Sanity Checking @ Decision Tree Analysis: Data has been collected and verified through cross-sanity checking the opinion and facts received from interview with the hypotheses framed from public databases. The team has verified the data by conduction both bottom-to-top and top-to-bottom analysis.

Future Forecasting via Poll Opinions and Statistical Tools: Multi-Factor regression was conducted on the lag variables by identifying the independent and quantifiable variables directly affecting the market. The forecasting was done by using SPSS statistical tools. The variables were checked for multi-co-linearity and other bias that could be present in the model. The conclusion from the regression was then double-checked by conducting poll opinions.

Interpretation and Proofreading: The final analysis will then be interpreted in the research report by our expert team well versed with the Healthcare Market.

Market Sizing:

We have followed bottom to top approach under which we were able to get the financials of leading domestic and international pharmaceutical companies in the country.

The market derived from last step is duly verified from annual report and investor presentation of the market players.

CATIs were conducted to confirm the overall market size and market share of respective segments, along with other details such as market segmentation, trends and major developments. Additionally, out team has also referred some of the public and proprietary databases to verify the market derived from the first step.


There might be a case that the chief executives / representatives might be bullish with the numbers. We have cross checked and revalidated the data, collected with our hypothesis and question them on the numbers. But in the end, justification provided by a primary might / might not be satisfactory on the numbers as there is no right mechanism to revalidate their numbers. However, to ascertain this, we have increased our sample size by approaching several pharmaceutical manufacturers in the country and asking about the market positioning of other companies from them.

Pharmaceutical Products:

Drug class including anti-infectives, gastrointestinal and metabolism, cardiovascular system, central nervous system, respiratory, musculoskeletal, dermatology, genitourinary and hormones, blood, oncology, endocrinology, ENT, ophthalmology, neonatology, genetic disease, immunology, Diabetes, infectious diseases, inflammation, internal diseases, metabolic diseases, nephrology, pulmonology, psychiatry, thrombosis and vitamin and dietary supplements.

Medical Devices:

Medical furniture, medical utensils, clothing medical and accessories, anthropometric equipment, hospital equipment, medical diagnostic equipment, resuscitation/ anesthesia equipment, surgical instrument, dressing devices, injection devices, surgical sutures, auxiliary devices, orthopedic devices, dental products, aesthetic devices, blood Transfusion devices, family planning devices, test kits and other disposables.

Non-Laboratory Tests:

Imaging tests involving Computed tomography (CT), Fluoroscopy, Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA), Mammography, Nuclear medicine, which includes such tests as a bone scan, thyroid scan, and thallium cardiac stress test, Plain X-rays, which includes chest X-ray, Positron emission tomography, also called PET imaging or a PET scan, ultrasound

Interventional radiology: Angiography or angioplasty and stent placement, Embolization, cancer treatments including tumor embolization using chemoembolization or Y-90 radioembolization, Tumor ablation with radiofrequency ablation, cryoablation, or microwave ablation, Vertebroplasty and kyphoplasty, Needle biopsies of different organs, such as the lungs and thyroid gland, Breast biopsy, guided either by stereotactic or ultrasound techniques, Uterine artery embolization, Feeding tube placement, Venous access catheter placement, such as ports and PICCs.

Variables Considered:

Number of Hospitals: An increase in number of healthcare centers will lead to an increase in accessibility of various healthcare services which will positively affect the revenue of Vietnam healthcare market.

Population: An increase in population will fuel the demand for healthcare services as proportion of aged population increases and number of visitors at clinical labs, pharmacies, hospitals and other healthcare center will increase.

Public Healthcare Expenditure: Increase in healthcare expenditure will lead to advanced healthcare infrastructure in the country and attract more number of medical tourists for both inbound and outbound patients

Prevalence of Diabetes: Increase in prevalence of diabetes will lead to an increase in demand for anti-diabetic products and healthcare services related to treatment of diabetes. This will positively affect the overall market revenue of Vietnam Healthcare Market.

Forecast Modelling:

The report applies Correlation and Regression analysis methods to forecast the future of the Vietnam Healthcare Market. The capabilities of SPSS and predictive analytics software have been leveraged to determine the relevant indicators used for forecasting this industry.

In the present case, healthcare market revenue has been taken as the dependent variable and other variables such as population, number of hospitals, public healthcare expenditure and prevalence of diabetes have been taken as independent variables.

For more information on the research report, refer to below link:

Related Reports

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications